Compare Piramal Healthcare with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ORCHID PHARMA LTD - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ORCHID PHARMA LTD PIRAMAL ENTERPRISES/
ORCHID PHARMA LTD
 
P/E (TTM) x 15.5 -0.5 - View Chart
P/BV x 1.0 0.1 836.6% View Chart
Dividend Yield % 1.8 0.0 -  

Financials

 PIRAMAL ENTERPRISES   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ORCHID PHARMA LTD
Sep-13
PIRAMAL ENTERPRISES/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs3,303194 1,702.4%   
Low Rs1,79735 5,133.7%   
Sales per share (Unadj.) Rs716.5276.5 259.2%  
Earnings per share (Unadj.) Rs79.7-79.2 -100.6%  
Cash flow per share (Unadj.) Rs107.9-43.5 -248.3%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.553.9 2,739.3%  
Shares outstanding (eoy) m184.4570.45 261.8%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x3.60.4 859.3%   
Avg P/E ratio x32.0-1.4 -2,213.0%  
P/CF ratio (eoy) x23.6-2.6 -896.7%  
Price / Book Value ratio x1.72.1 81.3%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2928,067 5,830.2%   
No. of employees `0007.82.8 279.3%   
Total wages/salary Rs m22,5042,527 890.5%   
Avg. sales/employee Rs Th16,899.46,956.1 242.9%   
Avg. wages/employee Rs Th2,877.7902.5 318.9%   
Avg. net profit/employee Rs Th1,879.9-1,993.0 -94.3%   
INCOME DATA
Net Sales Rs m132,15319,477 678.5%  
Other income Rs m3,128407 768.2%   
Total revenues Rs m135,28119,884 680.3%   
Gross profit Rs m66,2901,103 6,012.1%  
Depreciation Rs m5,2022,519 206.5%   
Interest Rs m44,0975,227 843.7%   
Profit before tax Rs m20,119-6,236 -322.6%   
Minority Interest Rs m3,19420 16,212.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m8,611-125 -6,878.0%   
Profit after tax Rs m14,701-5,580 -263.4%  
Gross profit margin %50.25.7 886.1%  
Effective tax rate %42.82.0 2,132.0%   
Net profit margin %11.1-28.7 -38.8%  
BALANCE SHEET DATA
Current assets Rs m122,74211,014 1,114.4%   
Current liabilities Rs m310,81032,060 969.5%   
Net working cap to sales %-142.3-108.1 131.7%  
Current ratio x0.40.3 115.0%  
Inventory Days Days2395 24.3%  
Debtors Days Days3934 115.7%  
Net fixed assets Rs m116,90429,440 397.1%   
Share capital Rs m369705 52.4%   
"Free" reserves Rs m272,1612,043 13,324.3%   
Net worth Rs m272,5303,800 7,172.0%   
Long term debt Rs m270,1969,018 2,996.2%   
Total assets Rs m856,26146,510 1,841.0%  
Interest coverage x1.5-0.2 -754.1%   
Debt to equity ratio x1.02.4 41.8%  
Sales to assets ratio x0.20.4 36.9%   
Return on assets %6.9-0.8 -903.5%  
Return on equity %5.4-146.9 -3.7%  
Return on capital %12.4-3.7 -332.6%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m15,2007,513 202.3%   
Fx outflow Rs m4,8895,649 86.5%   
Net fx Rs m10,3121,865 553.0%   
CASH FLOW
From Operations Rs m-115,9751,682 -6,896.3%  
From Investments Rs m-8,265-9,860 83.8%  
From Financial Activity Rs m107,5256,644 1,618.4%  
Net Cashflow Rs m-16,650-1,535 1,084.7%  

Share Holding

Indian Promoters % 52.9 32.3 163.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 4.6 87.0%  
FIIs % 26.6 3.3 806.1%  
ADR/GDR % 0.0 4.6 -  
Free float % 16.5 55.3 29.8%  
Shareholders   93,274 84,811 110.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 18, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - CIPLA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS